文献速递产科母胎医学

胎儿生长受限对早产子痫前期期待治疗孕妇妊娠结局的影响

Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-10-09

本研究对PIE和PI2随机对照试验数据进行二次分析,纳入202例26至32周子痫前期期待治疗孕妇,其中92例(45.5%)合并胎儿生长受限(FGR)。FGR组妊娠潜伏期中位数为6.8天,对照组为15.3天,FGR组达到34周妊娠的比例更低(12.0% vs 30.9%),因疑似胎儿窘迫剖宫产率更高(64.1% vs 36.4%),婴儿死亡率和需插管机械通气率均更高。

要点

  • 早产子痫前期期待治疗孕妇中FGR发生率为45.5%(92/202)。
  • FGR组妊娠潜伏期中位数为6.8天,对照组为15.3天。
  • FGR组婴儿死亡率14.1%,对照组4.5%(aRR 3.26)。

核心结论

  • FGR在早产子痫前期孕妇中常见,且结局更差。
  • FGR与更短的妊娠潜伏期、更多急诊剖宫产、更少成功引产及更高的新生儿发病率和死亡率相关。

研究设计与样本

  • 对PIE和PI2随机对照试验数据的二次分析。
  • PIE和PI2试验评估埃索美拉唑和二甲双胍能否延长26至32周确诊子痫前期并接受期待治疗孕妇的妊娠期。
  • 仅纳入PI2试验中的安慰剂数据,因该试验显示使用二甲双胍与妊娠期延长相关。
  • 共纳入202例孕妇,其中92例(45.5%)在子痫前期诊断时合并FGR(FGR采用Delphi共识定义)。
  • 所有结局数据从子痫前期诊断前瞻性收集至预产期后6周。

主要发现

  • FGR组妊娠潜伏期中位数为6.8天,对照组为15.3天(差值8.5天;调整后0.49倍变化,95%CI 0.33-0.74;P < 0.001)。
  • FGR组达到34周妊娠的比例为12.0%,对照组为30.9%(aRR 0.44,95%CI 0.23-0.83)。
  • FGR组因疑似胎儿窘迫分娩的比例为64.1%,对照组为36.4%(aRR 1.84,95%CI 1.36-2.47)。
  • FGR组产前急诊剖宫产比例为66.3%,对照组为43.6%(aRR 1.56,95%CI 1.20-2.03);FGR组成功引产比例为4.3%,对照组为14.5%(aRR 0.32,95%CI 0.10-1.00)。
  • FGR组婴儿死亡率为14.1%,对照组为4.5%(aRR 3.26,95%CI 1.08-9.81);FGR组需插管机械通气比例为15.2%,对照组为5.5%(aRR 2.97,95%CI 1.11-7.90)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess whether coexisting fetal growth restriction (FGR) influences pregnancy latency among women with preterm pre-eclampsia undergoing expectant management. Secondary outcomes assessed were indication for delivery, mode of delivery and rate of serious adverse maternal and perinatal outcomes. METHODS: We conducted a secondary analysis of the Pre-eclampsia Intervention (PIE) and the Pre-eclampsia Intervention 2 (PI2) trial data. These randomized controlled trials evaluated whether esomeprazole and metformin could prolong gestation of women diagnosed with pre-eclampsia between 26 and 32 weeks of gestation undergoing expectant management. Delivery indications were deteriorating maternal or fetal status, or reaching 34 weeks' gestation. FGR (defined by Delphi consensus) at the time of pre-eclampsia diagnosis was examined as a predictor of outcome. Only placebo data from PI2 were included, as the trial showed that metformin use was associated with prolonged gestation. All outcome data were collected prospectively from diagnosis of pre-eclampsia to 6 weeks after the expected due date. RESULTS: Of the 202 women included, 92 (45.5%) had FGR at the time of pre-eclampsia diagnosis. Median pregnancy latency was 6.8 days in the FGR group and 15.3 days in the control group (difference 8.5 days; adjusted 0.49-fold change (95% CI, 0.33-0.74); P < 0.001). FGR pregnancies were less likely to reach 34 weeks' gestation (12.0% vs 30.9%; adjusted relative risk (aRR), 0.44 (95% CI, 0.23-0.83)) and more likely to be delivered for suspected fetal compromise (64.1% vs 36.4%; aRR, 1.84 (95% CI, 1.36-2.47)). More women with FGR underwent a prelabor emergency Cesarean section (66.3% vs 43.6%; aRR, 1.56 (95% CI, 1.20-2.03)) and were less likely to have a successful induction of labor (4.3% vs 14.5%; aRR, 0.32 (95% CI, 0.10-1.00)), compared to those without FGR. The rate of maternal complications did not differ significantly between the two groups. FGR was associated with a higher rate of infant death (14.1% vs 4.5%; aRR, 3.26 (95% CI, 1.08-9.81)) and need for intubation and mechanical ventilation (15.2% vs 5.5%; aRR, 2.97 (95% CI, 1.11-7.90)). CONCLUSION: FGR is commonly present in women with early preterm pre-eclampsia and outcome is poorer. FGR is associated with shorter pregnancy latency, more emergency Cesarean deliveries, fewer successful inductions and increased rates of neonatal morbidity and mortality. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cluver CA, Bergman L, Bergkvist J, et al. Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2023. PMID: 37289938. doi:10.1002/uog.26282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。